Dr. Balfour studies the intersection of healthcare access and social issues, particularly for older adults who have been incarcerated. He investigates how stigma and systemic barriers affect their ability to get long-term care and reintegrate into the community. His research also encompasses pediatric health, looking at how to best protect children from conditions like meningococcal disease and the impacts of invasive procedures. Furthermore, he explores the economic and health costs associated with diseases like Group B Streptococcus in infants, highlighting the need for better preventive measures.
Key findings
Older adults previously incarcerated face significant care delays and denials, necessitating improved educational and advocacy efforts to aid their transition into long-term care facilities.
In a study of 212 uveitis patients, 50% had anterior uveitis, with 29% frequently returning to the clinic for severe conditions, pointing to specific treatment challenges within the population.
The economic burden of Group B Streptococcus disease on infants amounts to nearly double the healthcare costs of comparable infants without the disease, emphasizing the need for effective prevention strategies.
Among 132 children treated for Atrioventricular Node Reentry Tachycardia (AVNRT), 99% achieved symptom resolution after radiofrequency modification, with 89-93% remaining symptom-free for a year.
In a study on premature infants, 73% showed an increased immune response to meningococcal C vaccine by 12 months, indicating they might require an additional booster.
Frequently asked questions
Does Dr. Balfour study issues related to previously incarcerated individuals?
Yes, he studies the challenges faced by older adults who have been incarcerated, especially in accessing health care and reintegrating into society.
What treatments has Dr. Balfour researched for children?
He has researched effective treatments for pediatric conditions like Atrioventricular Node Reentry Tachycardia and meningococcal disease.
Is Dr. Balfour's work relevant to new parents?
Yes, his research on Group B Streptococcus disease significantly informs better prevention and care strategies for newborns.
What specific conditions does Dr. Balfour study in older adults?
He focuses on the transition challenges they face into long-term care, particularly those who have been previously incarcerated.
How does Dr. Balfour contribute to pediatric health?
He contributes by researching vaccine responses and minimizing risks during cardiac procedures, ensuring better health outcomes for children.
Publications in plain English
Community Reintegration of Previously Incarcerated Older Adults: Exploratory Insights from a Canadian Community Residential Facility Program.
2023
Journal of aging & social policy
Colibaba A, Skinner MW, Balfour G, Byrne D, Dieleman C
Plain English This study looked at how older men who were previously in jail adjust to life in the community after their release, specifically in Ontario, Canada. It found that these men face significant challenges accessing health care services, dealing with the stigma of their past, and lacking ongoing support to help them reintegrate smoothly. Understanding these issues is important for improving resources and support systems for older adults who have been incarcerated.
Who this helps: This helps patients, especially older men reentering society after incarceration.
Uveitis Patterns and Severity: An Epidemiologic Study from a Tertiary Care Private Referral Center in Buenos Aires, Argentina.
2023
Ocular immunology and inflammation
Julian LK, Balfour G, Forgues RF, de Smet MD, Suburo A
Plain English This study looked at patterns and severity of uveitis, an eye inflammation, in a group of 212 patients in Buenos Aires over four years. The researchers found that 50% of patients had anterior uveitis, and 29% needed to visit the clinic frequently due to severe cases, mostly those with posterior uveitis requiring strong medications. The study is important because it highlights how the local population, including a significant number of patients with Native American ancestry, may present unique challenges in treating uveitis.
Who this helps: This helps eye doctors and patients, particularly those with uveitis in Argentina.
Lost in transition? Community residential facility staff and stakeholder perspectives on previously incarcerated older adults' transitions into long-term care.
2023
BMC geriatrics
Poulin LIL, Colibaba A, Skinner MW, Balfour G, Byrne D +1 more
Plain English This research focused on understanding the challenges that older adults, who have been previously incarcerated, face when trying to access long-term care. The study found that these individuals often deal with delays or outright denial of care due to stigma and complex admission processes, highlighting their limited options in long-term care facilities. Improving transitional care methods, such as education and advocacy, can help these individuals, but significant changes are needed to make the admissions process fairer.
Who this helps: This helps previously incarcerated older adults seeking better access to long-term care.
Lifeline: A Qualitative Analysis of the Post Intervention Experiences of Human Trafficking Survivors and At-risk Women in Ghana.
2020
Journal of evidence-based social work (2019)
Balfour G, Callands T, Okech D, Kombian G
Plain English This study looked at the experiences of 37 women in Ghana who had been victims of human trafficking and had received help from a care center. The researchers found that while these women faced challenges in their lives, including social and economic issues, they still reported positive changes and achievements thanks to the support they received. This is important because it highlights the effectiveness of assistance programs in making a difference in the lives of survivors.
Who this helps: This helps survivors of human trafficking and the organizations that support them.
Optimization of hydrothermal synthesis of pure phase zeolite Na-P1 from South African coal fly ashes.
2012
Journal of environmental science and health. Part A, Toxic/hazardous substances & environmental engineering
Musyoka NM, Petrik LF, Gitari WM, Balfour G, Hums E
Plain English This study focused on finding the best way to create a substance called zeolite Na-P1 from coal ash, specifically from power plants in South Africa. The researchers discovered that using a mix of ingredients in the right amounts and treating the mixture at 140°C for 48 hours produced the highest quality zeolite, reaching a capacity of 4.11 milliequivalents per gram. These findings are important because they show how properly managing these processes can lead to better materials that could be useful in various applications, such as cleaning wastewater or capturing carbon.
Who this helps: This helps industries and researchers looking for effective materials for environmental applications.
Synthesis of hydroxy sodalite from coal fly ash using waste industrial brine solution.
2011
Journal of environmental science and health. Part A, Toxic/hazardous substances & environmental engineering
Musyoka NM, Petrik LF, Balfour G, Gitari WM, Hums E
Plain English Researchers studied how using industrial waste brine instead of pure water influences the creation of a substance called hydroxy sodalite from coal fly ash, a byproduct of burning coal. They found that the brine solution led to the successful formation of hydroxy sodalite, while also leaving some unwanted materials from the ash behind. This process is important because it offers a way to recycle waste materials and create useful products, reducing waste and potentially lowering costs for manufacturing.
Who this helps: This helps manufacturers looking for sustainable ways to produce materials.
The economic costs of Group B Streptococcus (GBS) disease: prospective cohort study of infants with GBS disease in England.
2009
The European journal of health economics : HEPAC : health economics in prevention and care
Schroeder EA, Petrou S, Balfour G, Edamma O, Heath PT +1 more
Plain English This study looked at the economic impact of Group B Streptococcus (GBS) disease on infants under 90 days old in England. Babies with GBS disease cost about £11,969 for their health and social care in their first two years, which is nearly double the £6,261 spent on comparable babies without the disease. Understanding these costs is important to guide decisions about how best to prevent and treat GBS disease in young children.
Who this helps: This information benefits doctors and healthcare policymakers.
Antibody responses to meningococcal (groups A, C, Y and W135) polysaccharide diphtheria toxoid conjugate vaccine in children who previously received meningococcal C conjugate vaccine.
2006
Vaccine
El Bashir H, Heath PT, Papa T, Ruggeberg JU, Johnson N +3 more
Plain English This study looked at how well a new meningococcal vaccine (MCV-4) works in young children who had previously received a vaccine against meningococcal group C. The researchers found that after one dose of MCV-4, the children's immune systems showed a strong response, especially toward group C, indicating that the new vaccine effectively boosted their protection. There were no significant differences in side effects between the children who got MCV-4 and those who received a control vaccine.
Who this helps: This benefits young children who are at risk for meningococcal disease and their healthcare providers.
Quantifying and minimizing radiation exposure during pediatric cardiac catheterization.
2005
Pediatric cardiology
Campbell RM, Strieper MJ, Frias PA, Jeager G, Balfour G +2 more
Plain English This study looked at ways to reduce radiation exposure for children during cardiac catheterization procedures. Researchers found that using pulsed fluoroscopy and lower power settings cut radiation exposure significantly compared to traditional high-power methods. Specifically, the study showed that radiation to sensitive areas like the thyroid was kept very low, helping to protect young patients from harm.
Who this helps: This benefits pediatric patients undergoing cardiac procedures.
Radiofrequency modification for inducible and suspected pediatric atrioventricular nodal reentry tachycardia.
2005
Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing
Strieper MJ, Frias P, Goodwin N, Huber G, Costello L +2 more
Plain English This study looked at a treatment called radiofrequency modification for children with a type of fast heartbeat known as Atrioventricular Node Reentry Tachycardia (AVNRT). Researchers found that among 132 patients, the treatment was very effective: 99% of those whose condition could be triggered during tests saw their symptoms go away after the procedure, with most remaining free of recurrences for a year. For those who couldn't trigger the condition during tests but still had symptoms, the treatment also worked well, with an 89-93% success rate in keeping their heart rates normal.
Who this helps: This benefits pediatric patients with AVNRT and their families.
Immunogenicity and immunologic memory of meningococcal C conjugate vaccine in premature infants.
2005
The Pediatric infectious disease journal
Collins CL, Ruggeberg JU, Balfour G, Tighe H, Archer M +8 more
Plain English This study looked at how well the meningococcal C vaccine works in premature infants compared to full-term babies. Both groups developed similar levels of protection after their initial vaccinations, but the defense weakened significantly by age 1. When tested again at 12 months, 73% of the preterm infants showed an increase in protective response, compared to 88% of the full-term infants, suggesting that preterm babies might need an additional booster shot to maintain their immunity.
Who this helps: This benefits premature infants who are at higher risk for infections and may need extra protection.
Group B streptococcal disease in UK and Irish infants younger than 90 days.
2004
Lancet (London, England)
Heath PT, Balfour G, Weisner AM, Efstratiou A, Lamagni TL +7 more
Plain English This study looked at group B streptococcal disease in infants under 90 days old in the UK and Ireland, identifying 568 cases during 2000-2001. The study found that about 1 in 1,000 newborns were affected, with 377 cases occurring early (before 7 days old) and 191 later, leading to a death rate of nearly 10%. Understanding how common this disease is helps create better prevention guidelines, which is crucial for protecting newborns.
Who this helps: This benefits newborns and their parents by improving awareness and prevention strategies.
Osteomyelitis and sepsis: severe complications of fetal monitoring.
1975
Pediatrics
Overturf GD, Balfour G
Plain English This study looked at the serious complications that can arise from advanced fetal monitoring during labor. Researchers reported two cases: one infant developed a bone infection (osteomyelitis) and another had a severe bacterial infection (streptococcal sepsis). These findings highlight the need for better awareness of possible negative effects and the importance of creating safer monitoring methods.
Who this helps: This helps infants and the medical professionals monitoring their health during childbirth.